Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 40, Issue 6, Pages 1821-1830Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2012.1391
Keywords
bladder cancer; microRNA miR-1; miR-133; prothymosin-alpha; purine nucleoside phosphorylase
Categories
Funding
- Ministry of Education, Science, Sports, and Culture [23501298, 23791764]
- Grants-in-Aid for Scientific Research [23501298, 24791636, 23791764] Funding Source: KAKEN
Ask authors/readers for more resources
Our expression signatures of human cancer including bladder cancer (BC) revealed that the expression of microRNA-1 (niR-1) and microRNA-133a (miR-133a) is significantly reduced in cancer cells. In the human genome, miR-1 and miR-133a are located on the same chromosomal region (miR-1-2 and miR-133a-1 on 18q11.2, and miR-1-1 and miR-133a-2 on 20q13.33) called cluster. In this study, we identified the novel molecular targets commonly regulated by miR-1-1 and miR-133a in BC. Genome-wide molecular target search and luciferase reporter assays showed that prothymosin-alpha (PTMA) and purine nucleoside phosphorylase (PNP) are directly regulated by miR-1 and miR-133a. Silencing of these two genes significantly inhibited cell proliferation and invasion, and increased apoptosis in BC cells. Immunohistochemistry showed that PTMA expression levels were significantly higher in BC compared to normal bladder epitheliums. PTMA and PNP were identified as new target genes regulated by the miR-1 and miR-133a cluster in BC. These genes may function as oncogenes contributing to cell proliferation and invasion in BC. Tumor suppressive miR-1 and miR-133a-mediated novel molecular targets may provide new insights into the potential mechanisms of BC oncogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available